Technology news for families navigating serious mental illness — translated so you don’t have to.
This week’s stories all circle the same question: the tools are getting more capable, but who’s actually checking whether they’re being used responsibly?
The accountability gap
A new piece in Cureus makes the case bluntly: chatbots, symptom checkers, and AI companions are scaling across mental health care faster than any oversight can keep up with. This is the same gap I’ve been pointing to since before the book came out — the tools can genuinely help, but “available” and “accountable” are not the same thing, and nobody hands you that distinction when you’re desperate for support.
Who’s watching the monitors
Two related stories out of the UK this week: the BBC reports that an official inquiry heard there’s a lack of solid evidence behind Oxevision, a widely deployed patient-monitoring system in psychiatric wards. A separate BBC piece on a different monitoring rollout found that only 42% of patients had actually consented to its use. If you’ve ever wondered whether a facility’s “we use technology to keep patients safe” line has real evidence behind it, this is worth reading — consent and evidence are exactly the questions families should be asking before any monitoring tech gets used on a loved one.
AI at the front door
In San Francisco, city officials publicly called Kaiser’s approach to AI in mental health “unacceptable,” pointing to patients who can’t get a human appointment being routed to AI tools instead. Meanwhile, a clinician writing in Healthcare IT Today makes the more hopeful counterpoint: AI has a real, useful role at the “front door” of care — triage, access, first contact — as long as it’s a bridge to a human clinician, not a substitute for one. Both stories are really about the same line: technology extending care versus technology replacing it.
For your toolkit
Everyday Health has a genuinely practical rundown on symptom tracking for schizophrenia — the goal being functional recovery, not just symptom suppression. If you’re not already using a tracker with your loved one’s care team, this is a good, gentle place to start that conversation.
For your care team
Two clinician-facing pieces from Psychiatric Times on crisis planning and care transitions and access — including a candid discussion of telepsychiatry and long-acting injectables. Worth passing along to your psychiatrist if you haven’t seen these yet; it’s useful to know what’s actually being discussed at the clinical level.
Follow the blog at ResourcesforSMI.com. Subscribe today!
